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INTRODUCTION
Gliomas account for 40% to 67 % of primary brain tumors (Preston –Martin 1996) and 
they  include  astrocytomas,  oligodendrogliomas,  ependymomas,  mixed  gliomas  (29) .These 
tumors are neuro-epithelial in origin.
In 1863 Virchow, the founder of cellular pathology coined the term glioma and in 1926 
Bailey  and  Cushing  classified  these  tumors  based  on  histiogenesis  ,  morphological 
characteristics  and  biological  behaviour  and  later  on  was  modified  by  others  including 
Penfield ,Cone and Elvidge .
 There has been various other  grading  systems for gliomas they include Kernohan 
grading system ,  St.  Anne Mayo and the recent WHO classification(41).  They are based on 
histological presence of nuclear atypia , mitosis , endothelial proliferation and necrosis .
Of the gliomas ,  astrocytomas are  common and they represent 26.6 % of  all  newly 
diagnosed primary brain glial tumors .and oligodendrogliomas 2.1 % (Mahaley  1989) (19).
Gliomas are intrinsic parenchymal lesions of brain which when present in higher grades 
are associated with mass effect and midline shift and associated  with poor prognosis .Gliomas 
present most commonly with seizures in one half  of the patients and in low grade gliomas in 
the other half patients appear neurologically intact ( Schuurman  1997 )(35).
 The prognosis of these tumors depend on age of the patients , performance scale of the 
patient , duration of symptoms , pre operative neurological deficit,  the  extend of resection of 
tumour , the grade of tumour, adjuvant therapy given and these well known factors have been a 
matter of debate  and they are analysed in thus study
      With the invention of new imaging techniques, microsurgical techniques and adjuvant 
therapy and other modalities of treatment the prognosis has improved  over  the  years .
There remains a subset of patients in whom the above said therapies when given in an 
apt manner can improve the outcome .This study was hence undertaken to find the impact of 
the prognostic factors in the outcome of  supratentorial gliomas and to apply a new  prognostic 
scoring  in those patient selected .It also aims  to find out whether this scoring can be applied in 
patients with glioma to predict the outcome . 
 
AIM OF STUDY
    This study aims at studying the various prognostic factors in supratentorial gliomas and to do 
a preliminary evaluation of a new prognostic scoring system   for supratentorial gliomas
REVIEW OF LITERATURE
There have been many studies on prognostic factors in glioma. Both retrospective and 
prospective .Many pioneering authors have made studies on age ,  performance of  patients, 
grading of gliomas , extend of resection and the radiological characteristics.
Even though the gliomas formed 40 to 67 % in a study done by Preston-martin  (29) a 
study done by Dastur  , Ramamurthi , Lalitha in 1980 had a lower incidence 35.2 %, 42.5% , 
35.8 %, 29.3%  in the cities of Mumbai , Delhi, Vellore and Chennai (8).
The  incidence  of  male:female  in  astrocytomas  and  oligodendrogliomas   is  1.5  :  1 
according to Velema (1987) (40) , while Chandra  (1983) reported a ratio of 3:1 (5) .
Frontal lobe is the most common location followed by temporal and paraietal lobes is 
what the studies of Zulch (1986) had concluded (43).
Long duration of symptoms was proven as a favorable factor for survival ina study done 
by Taekuchi in1977 (38).
Burger & Green   (1987) have studied in 71 patients with high grade glioma the role of 
patient’s age ,  histology features and length of survival of patients (4)
          Wood & Shapiro (1988) in 510 patients have studied about the tumor size in computed 
tomographic scan  preoperative and post operatively and had concluded that greater the tumor 
resection greater the length of survival for the patients (43).
            A higher Karnofsky score after surgery was associated with good outcome according to 
Winger 1989 (42).
Macdonald   (1990)   in his  retrospective study in  285 patients  had concluded that 
patients with gross total resection lived longer than patients with partial or a biopsy .And they 
also stated that age , duration of symptoms, pre-operative performance scale , tumor histology, 
extend of resection and prior low –grade glioma were significant variables influencing survival 
(17).
              Crooks,  Waller (1991) have published a detailed account on karnofskys scale in patients 
of glioma (6).
KARNOFSKY PERFORMANCE STATUS SCALE DEFINITIONS RATING (%) 
CRITERIA  
Able to carry on normal activity and to 
work; no special care needed.
  100  Normal no complaints; no evidence of disease.
90
Able to carry on normal activity; 
minor signs or symptoms of 
disease.
80
Normal activity with effort; 
some signs or symptoms of 
disease. 
Unable to work; able to live at home 
and care for most personal needs; 
varying amount of assistance needed.
70
Cares for self; unable to carry on 
normal activity or to do active 
work.
60
Requires occasional assistance, 
but is able to care for most of his 
personal needs.
50 Requires considerable assistance and frequent medical care. 
Unable to care for self; requires 
equivalent of institutional or hospital 
care; disease may be progressing 
rapidly.
40
Disabled; requires special care 
and assistance.
30
Severely disabled; hospital 
admission is indicated although 
death not imminent.
20
Very sick; hospital admission 
necessary; active supportive 
treatment necessary.
10 Moribund; fatal processes progressing rapidly.
0 Dead
       Keeping in mind the general principles of tumor elsewhere  in the body , a total excision 
would be a ideal choice . This is not always possible , because of the location of the tumor in or 
near a eloquent area , its infiltrating nature and difficulty in ascertaining the precise limits of its 
extent during surgery (Kornbllith , 1991 ) (13) .
             Dedifferentiation or malignant transformation is a well – described phenomenon in low 
grade gliomas around 13% to 86 % of tumors initially diagnosed as low grade recur at a higher 
histological grade  according to Berger 1994 (2) and  McCormack 1992 (21)
               Studies  by  McCormack  1992  showed that  enhancement  with  contrast  in 
computerized tomogram (CT)  had a negative outcome in terms of survival(21) .It was also stated 
by Wu , Lang , Du 1991 that it was not possible to ascertain the grade of malignancy or the 
histological subtypes using CT (45).
       Extension into deeper structures  and across the midline though not a contraindication for a 
radical surgery  would preclude a surgeon from total excision of the tumor  (Tandon 1993 )(37).
             Curran Jr (1993) has prognostically classified gliomas based on age, performance 
status, Histology , Neurological function , duration of symptoms and  extend of resection (7).
   Macdonald  and Mullan in (1994)  have studied in 75 patients have quantitatively 
analysed the extend of resection with pre and post operative scans to determine the effect of 
extend of resection on survival of patients with astrocytomas (18).
De Angelis (2001) has studied the incidence of symptoms in low grade and high grade 
gliomas and have found the median survival for the four grades of glioma (9).
 The median of low grade gliomas was 35 yrs which was considerably lower than high 
grade gliomas according to Laws (2001) (16).
       Scott   (2008) has studied the role of extend of resection in the long-term outcome 
of low grade hemispheric gliomas (36).
MATERIALS AND METHODS
This study was done in 102 patients  of glioma ,  which was operated in  Institute of 
neurology, Madras Medical College and Government General Hospital, Chennai.  This was 
both prospective and retrospective study  with a mean follow up period of 2.5 yrs.
Inclusion criteria :
1. Patients  with  supratentorial  gliomas  with  preoperative  and  postoperative  contrast 
computed tomographic scan  and with regular followup
Exclusion criteria
1) Patients who did not have a post operative imaging .
2) Patients operated in some other hospital and referred to our hospital
       A proforma was made and based on the above criteria  102 patients were selected  .It is a 
prospective and retrospective study .  
            In retrospective study based on old records patients were enrolled in this study  apart 
from basic investigations computed tomogram plain and contrast was taken and the volume of 
tumor was calculated based on Di Chiros formula- AxBxC/2 , where A is the length, B is the 
breath , C is the height of the tumor. The presence of mass effect and  edema was noted. The 
extent of resection was calculated from that formula after taking post operative scan as given in 
Appendix - III. The follow up ranged from 2 months to 14 years. In the prospective study the 
patients were followed after admission to the hospital and the details were collected  from a 
period of 2005 to 2008. The details were entered in the Proforma (as given in Appendix – I). 
         In the post operative period, the performance status of the patient was noted and after 
histopathological  examination  the  grading  of  the  tumor  was  recorded  and  patients  were 
followed after radio therapy and chemotherapy. Based on the above details a master chart was 
prepared. A new prognostic scoring system for supratentorial gliomas has been evolved in this 
Institute and a preliminary evaluation of the scoring system has been under taken during this 
study. The details of the scoring system are given in the table below and master chart was made 
(seen in Appendix – II). 
     The effect of various individual prognostic factors and the total score of the new prognostic 
scale on the outcome on follow up was evaluated using statistical  methods.  The statistical 
methods  used  were  SPSS  package(Edition  13.0),   Pearson  Chi-Square,  Likelihood  Ratio, 
Fisher’s Exact Test and Spearman Correlation. 
NEW PROGNOSTIC SCALE FOR SUPRATENTORIAL GLIOMAS
   PROGNOSTIC  FACTORS SUB – DIVISIONS SCORE
AGE
< 45 yrs 
45- 64    
> 65       
3
2
1
KARNOFSKYS PERFORMANCE 
SCALE (KPS)
> 80      
50 – 70 
< 40    
3
2
1
DURATION OF SYMPTOMS 1 Yrs  1 month – 1 Yr 
< 1 month   
3
2
1
RADIOLOGICAL PARAMETER
No necrosis, No mass 
effect 
No necrosis, Mass effect 
Necrosis and Mass 
effect
3
  
2
1
GRADING OF TUMOR Grade 1 &2  Grade   3  
Grade   4 
3
2
1
EXTENT OF RESECTION
> 95 % Resection  
< 95  % resection 
Biopsy               
3
2
1
Maximum Score = 18
Minimum Score = 6
RESULTS
AGE Vs OUTCOME  
AGE  DISTRIBUTION
  
Frequenc
y
Perce
nt Valid Percent Cumulative Percent
Valid >65yrs 2 1.96 1.960784314 1.960784314
45 - 64 34 33.33 33.33333333 35.29411765
<45yrs 66 64.71 64.70588235 100
Total 102 100.00 100
Age_r  Frequency
Expired >65yrs 1
 45 - 64 9
 <45yrs 3
 Total 13
Deteroiated 45 - 64 20
 <45yrs 25
 Total 45
Static >65yrs 1
 45 - 64 5
 <45yrs 24
 Total 30
Improved <45yrs 14
In the category of patients who have improved all patients were below the 45 yrs group 
as evidenced by crosstab test. In the >65 yrs category 50 % of the patients who had glioma 
expired as in crosstab-1 .
SEX Vs OUTCOME  
SEX  DISTRIBUTION 
  Frequency Percent Valid Percent
Cumulative 
Percent
Valid Male 67 65.69 65.68627451 65.68627451
Female 35 34.31 34.31372549 100
Total 102 100.00 100
Crosstab.1
1 9 3
13
7.7% 69.2% 23.1% 100.0%
50.0% 26.5% 4.5% 12.7%
0
20 25 45
.0% 44.4% 55.6% 100.0%
.0% 58.8% 37.9% 44.1%
1 5
24 30
3.3% 16.7% 80.0% 100.0%
50.0% 14.7% 36.4% 29.4%
0 0 14 14
.0% .0% 100.0% 100.0%
.0% .0% 21.2% 13.7%
2 34 66 102
2.0% 33.3% 64.7% 100.0%
100.0% 100.0% 100.0% 100.0%
Count
% within event
% within age_r
Count
% within event
% within age_r
Count
% within event
% within age_r
Count
% within event
% within age_r
Count
% within event
% within age_r
 expired
deteroiated
static
improved
Outcome
Total
>65yrs 45 - 64 <45yrs
age_r
Total
Sex_r  Frequency
Expired Male 7
 Female 6
 Total 13
Deteroiated Male 28
 Female 17
 Total 45
Static Male 24
 Female 6
 Total 30
Improved Male 8
 Female 6
 Total 14
     Males seem to have higher incidence of gliomas , but there was no significant correlation 
between males and females in terms of survival and prognosis .
Crosstab.2
7 6
13
53.8% 46.2% 100.0%
10.4% 17.1% 12.7%
28 17 45
62.2% 37.8% 100.0%
41.8% 48.6% 44.1%
24 6 30
80.0% 20.0% 100.0%
35.8% 17.1% 29.4%
8 6
14
57.1% 42.9% 100.0%
11.9% 17.1% 13.7%
67 35 102
65.7% 34.3% 100.0%
100.0% 100.0% 100.0%
Count
% within event
% within sex_r
Count
% within event
% within sex_r
Count
% within event
% within sex_r
Count
% within event
% within sex_r
Count
% within event
% within sex_r
   expired
deteroiated
static
improved
Outcome
Total
Male Female
sex_r
Total
KPS   Vs OUTCOME  
KPS  DISTRIBUTION 
  Frequency
Perce
nt Valid Percent Cumulative Percent
Vali
d 40 below 2 1.96 1.960784314 1.960784314
50 - 70 33 32.35 32.35294118 34.31372549
80 above 67 65.69 65.68627451 100
Total 102 100.00 100
15.38
61.54
23.08
44.44
55.56
13.33
86.67
7.14
92.86
0
20
40
60
80
100
Fr
eq
(%
)
Expired Static
Events
<40 50  - 70 >80
KPS_r  Frequency
Expired 40 below 2
 50 - 70 8
 80 above 3
 Total 13
Deteroiated 50 - 70 20
 80 above 25
 Total 45
Static 50 - 70 4
 80 above 26
 Total 30
Improved 50 - 70 1
 80 above 13
 Total 14
      There is a significant correlation of  outcome and KPS .Patients who had a score below 40 
had expired .Most of the patients who had a score above 80 had improved after surgery .
Crosstab.3
2 8 3 13
15.4% 61.5% 23.1% 100.0%
100.0% 24.2% 4.5% 12.7%
0
20 25 45
.0% 44.4% 55.6% 100.0%
.0% 60.6% 37.3% 44.1%
0 4
26 30
.0% 13.3% 86.7% 100.0%
.0% 12.1% 38.8% 29.4%
0 1 13 14
.0% 7.1% 92.9% 100.0%
.0% 3.0% 19.4% 13.7%
2 33 67 102
2.0% 32.4% 65.7% 100.0%
100.0% 100.0% 100.0% 100.0%
Count
% within event
% within kps_r
Count
% within event
% within kps_r
Count
% within event
% within kps_r
Count
% within event
% within kps_r
Count
% within event
% within kps_r
expired    
deteroiated
static
improved
outcome
Total
40 below 50 - 70 80 above
kps_r
Total
DURATION OF SYMPTOMS Vs.  OUTCOME  
DISTRIBUTION OF DURATION OF SYMPTOMS
  Frequency Percent Valid Percent
Cumulative 
Percent
Vali
d <1month 7 6.86 6.862745098 6.862745098
1mnt-1yr 88 86.27 86.2745098 93.1372549
>1yr 7 6.86 6.862745098 100
Total 102 100.00 100
30.77
69.23
4.44
93.33
2.22 3.33
93.33
3.33
64.29
35.71
0
20
40
60
80
100
Fr
eq
(%
)
Expired Deteroiated Static Improved
Events
<1month 1mnt-1yr >1yr
Duration  Frequency
Expired <1month 4
 1mnt-1yr 9
 Total 13
Deteroiated <1month 2
 1mnt-1yr 42
 >1yr 1
 Total 45
Static <1month 1
 1mnt-1yr 28
 >1yr 1
 Total 30
Improved 1mnt-1yr 9
 >1yr 5
 Total 14
 Patients who were symptomatic for long had improved or remained static after surgery 
as evidenced by crosstab .But patients who had short duration of symptoms either  deteriorated 
or expired following surgery .
Crosstab.4
4 9 0 13
30.8% 69.2% .0% 100.0%
57.1% 10.2% .0% 12.7%
2
42
1
45
4.4% 93.3% 2.2% 100.0%
28.6% 47.7% 14.3% 44.1%
1
28
1
30
3.3% 93.3% 3.3% 100.0%
14.3% 31.8% 14.3% 29.4%
0 9 5 14
.0% 64.3% 35.7% 100.0%
.0% 10.2% 71.4% 13.7%
7 88 7 102
6.9% 86.3% 6.9% 100.0%
100.0% 100.0% 100.0% 100.0%
Count
% within event
% within dur
Count
% within event
% within dur
Count
% within event
% within dur
Count
% within event
% within dur
Count
% within event
% within dur
expire
dd
deteroiated
static
improved
outcome
Total
<1month 1mnt-1yr >1yr
dur
Total
IMAGING  FINDINGS Vs. OUTCOME
DISTRIBUTION OF IMAGING FINDINGS
  
Frequenc
y
Perce
nt
Valid 
Percent
Cumulative 
Percent
Vali
d necrosis & mass effect 4 3.92 3.921568627 3.921568627
no necrosis, mass effect 79 77.45 77.45098039 81.37254902
no necrosis, no mass effect 19 18.63 18.62745098 100
Total 102 100.00 100
15.38
84.62
4.44
93.33
2.22
76.67
23.33 21.43
78.57
0
20
40
60
80
100
Fr
eq
(%
)
Expired Deteroiated Static Improved
Events
Nec&masseffect No nec&masseffect no nec&no masseffect
Imaging  Frequency
Expired necrosis & mass effect 2
 no necrosis, mass effect 11
 Total 13
Deteroiated necrosis & mass effect 2
 no necrosis, mass effect 42
 no necrosis, no mass effect 1
 Total 45
Static no necrosis, mass effect 23
 no necrosis, no mass effect 7
 Total 30
Improved no necrosis, mass effect 3
 no necrosis, no mass effect 11
 Total 14
Crosstab.5
2 11 0 13
15.4% 84.6% .0% 100.0%
50.0% 13.9% .0% 12.7%
2
42
1
45
4.4% 93.3% 2.2% 100.0%
50.0% 53.2% 5.3% 44.1%
0 23 7 30
.0% 76.7% 23.3% 100.0%
.0% 29.1% 36.8% 29.4%
0 3 11 14
.0% 21.4% 78.6% 100.0%
.0% 3.8% 57.9% 13.7%
4
79 19 102
3.9% 77.5% 18.6% 100.0%
100.0% 100.0% 100.0% 100.0%
Count
% within event
% within imaging
Count
% within event
% within imaging
Count
% within event
% within imaging
Count
% within event
% within imaging
Count
% within event
% within imaging
      expired
deteroiated
static
improved
outcome
Total
necrosis &
mass effect
no necrosis,
mass effect
no necrosis,
no mass
effect
imaging
Total
Presence of mass effect , edema ,and necrosis is associated with poorer prognosis in 
terms of survivability and outcome where as patients who did not have the above features had 
better outcome
EXTENT  OF  RESECTION Vs. OUTCOME
DISTRIBUTION OF EXTENT OF RESECTION 
  
Frequenc
y Percent Valid Percent Cumulative Percent
Valid 1 5 4.90 4.901960784 4.901960784
2 91 89.22 89.21568627 94.11764706
3 6 5.88 5.882352941 100
Total 102 100.00 100
 > 95% Resection – 3
 < 95% Resection – 2
 Biopsy – 1
23.08
69.23
7.69
2.22
88.89
8.89
3.33
93.33
3.33
100
0
20
40
60
80
100
freq(%)
Expired Deteroiated Static Improved
Events
Biopsy res.tumor>5% res.tumor<5%
Ext.res  Frequency
Expired 1 3
 2 9
 3 1
 Total 13
Deteroiated 1 1
 2 40
 3 4
 Total 45
Static 1 1
 2 28
 3 1
 Total 30
Improved 2 14
Crosstab.6
3 9 1
13
23.1% 69.2% 7.7% 100.0%
60.0% 9.9% 16.7% 12.7%
1 40 4 45
2.2% 88.9% 8.9% 100.0%
20.0% 44.0% 66.7% 44.1%
1 28 1 30
3.3% 93.3% 3.3% 100.0%
20.0% 30.8% 16.7% 29.4%
0
14
0
14
.0% 100.0% .0% 100.0%
.0% 15.4% .0% 13.7%
5
91
6
102
4.9% 89.2% 5.9% 100.0%
100.0% 100.0% 100.0% 100.0%
Count
% within event
% within ext.res
Count
% within event
% within ext.res
Count
% within event
% within ext.res
Count
% within event
% within ext.res
Count
% within event
% within ext.res
      Expired
deteroiated
static
improved
outcome
Total
1 2 3
ext.res
Total
More than 95 % resection is associated with increased survivability and in patients in 
whom only biopsy was done a majority has deteriorated or expired as seen in cross tab test .
GRADING  OF TUMOR  Vs. OUTCOME
DISTRIBUTION OF GRADING OF TUMOR
  Frequency Percent Valid Percent Cumulative Percent
Valid IV 39 38.24 38.23529412 38.23529412
III 6 5.88 5.882352941 44.11764706
I&II 57 55.88 55.88235294 100
Total 102 100.00 100
92.31
7.69
46.67
8.89
44.44
16.67
3.33
80
7.14
92.86
0
20
40
60
80
100
Fr
eq
(%
)
Expired Deteroiated Static Improved
Events
IV III I&II
Grade_r  Frequency
Expired IV 12
 III 1
 Total 13
Deteroiated IV 21
 III 4
 I&II 20
 Total 45
Static IV 5
 III 1
 I&II 24
 Total 30
Improved IV 1
 I&II 13
 Total 14
   
   There  is  a  positive  correlation  between  grading  and  prognosis.  Low grade  tumors  are 
associated with good prognosis and higher grade patients are associated with worst prognosis 
as the above crosstab .
Crosstab.7
12
1 0
13
92.3% 7.7% .0% 100.0%
30.8% 16.7% .0% 12.7%
21 4 20 45
46.7% 8.9% 44.4% 100.0%
53.8% 66.7% 35.1% 44.1%
5 1 24 30
16.7% 3.3% 80.0% 100.0%
12.8% 16.7% 42.1% 29.4%
1 0
13 14
7.1% .0% 92.9% 100.0%
2.6% .0% 22.8% 13.7%
39
6
57 102
38.2% 5.9% 55.9% 100.0%
100.0% 100.0% 100.0% 100.0%
Count
% within event
% within grade_r
Count
% within event
% within grade_r
Count
% within event
% within grade_r
Count
% within event
% within grade_r
Count
% within event
% within grade_r
       expired
deteroiated
static
improved
outcome
Total
IV III I&II
grade_r
Total
OUTCOME
DISTRIBUTION OF OUTCOME 
  Frequency Percent
Valid 
Percent
Cumulative 
Percent
Vali
d expired 13 12.75 12.74509804 12.74509804
deteroiated 45 44.12 44.11764706 56.8627451
static 30 29.41 29.41176471 86.2745098
improved 14 13.73 13.7254902 100
Total 102 100.00 100
13
45
30
14
0
10
20
30
40
50
Expired Deteroiated Static Improved
Events
no of patients
SCORE  Vs. OUTCOME
DISTRIBUTION OF SCORING
  Frequency Percent Valid Percent
Cumulative 
Percent
Valid <10 7 6.86 6.862745098 6.862745098
11-14 55 53.92 53.92156863 60.78431373
>15 40 39.22 39.21568627 100
Total 102 100.00 100
30.77
69.23
2.22
80
17.78
6.67
26.67
66.67
14.29
85.71
0
10
20
30
40
50
60
70
80
90
Fr
eq
(%
)
Expired Deteroiated Static Improved
Events
<10 11 TO 14 15 TO 18
Score_r  Frequency
Expired <10 4
 11-14 9
 Total 13
Deteroiated <10 1
 11-14 36
 >15 8
 Total 45
Static <10 2
 11-14 8
 >15 20
 Total 30
Improved 11-14 2
 >15 12
 Total 14
Score Vs. Outcome : A  score  <  10  was  associated 
with  poor  outcome in  significant  number  of  patients  with 
supratentorial  gliomas.  A score  >  15  was  associated  with 
Good Outcome.
DISTRIBUTION OF NEUROLOGICAL  DEFICIT
Neurological Deficit
Frequenc
y
Perce
nt
Valid 
Percent
Cumulative 
Percent
Vali
d Attaxic gait 1 0.98 0.980392157 0.980392157
Dec.vision 1 0.98 0.980392157 1.960784314
Dysphasia 5 4.90 4.901960784 6.862745098
Functional.dis 6 5.88 5.882352941 12.74509804
UMN Faciallag 36 35.29 35.29411765 48.03921569
Hemiparesis 1 0.98 0.980392157 49.01960784
Homonymous hemianopia 2 1.96 1.960784314 50.98039216
Monoparisis 1 0.98 0.980392157 51.96078431
Nil 22 21.57 21.56862745 73.52941176
Paraperesis 2 1.96 1.960784314 75.49019608
Optic atrophy.sec 1 0.98 0.980392157 76.47058824
Papilloedema 21 20.59 20.58823529 97.05882353
Slurring speech 1 0.98 0.980392157 98.03921569
Unconscious 1 0.98 0.980392157 99.01960784
6th nerve paresis 1 0.98 0.980392157 100
Total 102 100.00 100
     Hemiparesis and papilloedema was the most common neurological deficit as seen in the 
above table.
DISTRIBUTION  OF  SYMPTOMS
 Symptoms 
Frequen
cy
Perce
nt
Valid 
Percent
Cumulative 
Percent
Vali
d Alt.sensorium 5 4.90 4.901960784 4.901960784
Blurring  of vision 1 0.98 0.980392157 5.882352941
Decreased vision 1 0.98 0.980392157 6.862745098
Headache 56 54.90 54.90196078 61.76470588
Double Vision 1 0.98 0.980392157 62.74509804
Headache + vomit 1 0.98 0.980392157 63.7254902
Hemiparesis 1 0.98 0.980392157 64.70588235
Focal Seizures 28 27.45 27.45098039 92.15686275
Generalized Seizures 1 0.98 0.980392157 93.1372549
Slowness of activity 1 0.98 0.980392157 94.11764706
Eye Pain 1 0.98 0.980392157 95.09803922
Vomit 1 0.98 0.980392157 96.07843137
Weakness 4 3.92 3.921568627 100
Total 102 100.00 100
Head ache and Seizures are the most common symptom as seen the above table.
 SYMPTOMS  Vs.  OUTCOME
Outcome Symptoms Frequency Percent
Expired Alt.sensorium 3 23.08
 Headache 6 46.15
 Hemiparesis 1 7.69
 Seizures 3 23.08
 Total 13 100.00
Deteroiated Alt.sensorium 1 2.22
 Headache 27 60.00
 Seizures 13 28.89
 Decreased vision 1 2.22
 Slowness of activity 1 2.22
 Vision 1 2.22
 Weakness 1 2.22
 Total 45 100.00
Static Alt.sensorium 1 3.33
 Headache 14 46.67
 Generalised 10 33.33
 Weakness 3 10.00
 Focal Seizure 1 3.33
 Vomit 1 3.33
 Total 30 100.00
Improved Headache 9 64.29
 Seizures 2 14.29
 Blurring  of vision 1 7.14
 Headache 1 7.14
 Headache + Vomit 1 7.14
 Total 14 100.00
SITE  Vs.  OUTCOME
Outcome Site Frequency Percent
Expired C.callosum 2 15.38
 L.frontal 1 7.69
 L.paraietal 2 15.38
 Multifocal 1 7.69
 R.frontal 4 30.77
 R.paraietal 3 23.08
 Total 13 100.00
Deteroiated C.callosum 3 6.67
 L.frontal 1 2.22
 L.paraietal 12 26.67
 R.frontal 13 28.89
 R.paraietal 2 4.44
 L.temporal 2 4.44
 R.insular 1 2.22
 R.tempora 9 20.00
 R.thalamic 2 4.44
 Total 45 100.00
Static C.callosum 1 3.33
 L.frontal 1 3.33
 L.paraietal 10 33.33
 R.frontal 9 30.00
 R.paraietal 3 10.00
 L.temporal 2 6.67
 R.tempora 3 10.00
 L.thalamic 1 3.33
 Total 30 100.00
Improved R.frontal 6 42.86
 R.paraietal 4 28.57
 L.temporal 1 7.14
 R.tempora 1 7.14
 L.thalamic 1 7.14
 Suprasellar 1 7.14
 Total 14 100.00
   Right frontal lobe is the most common location of supratentorial gliomas as seen in the above 
Table.
SPEARMAN  CORRELATION
  age_r sex_r kps_r dur imaging grade_r ext.res event score_r totalscore
Spear
man's 
age_r
Correlation 
Coefficient 1 -0.01686 0.270128 0.289531 0.250369 0.401119 0.143175 0.456193 0.649348 0.640569
 
Sig. (2-
tailed) . 0.866425 0.006037 0.003162 0.011149 2.94E-05 0.151122 1.45E-06 0.000001 0.000001
 N 102 102 102 102 102 102 102 102 102 102
sex_r
Correlation 
Coefficient -0.01686 1 0.080635 0.05574 -0.17696 0.043176 -0.08471 -0.10032 0.044792 -0.01917
 
Sig. (2-
tailed) 0.866425 . 0.420445 0.577911 0.075196 0.666555 0.397248 0.315728 0.654856 0.848338
 N 102 102 102 102 102 102 102 102 102 102
kps_r
Correlation 
Coefficient 0.270128 0.080635 1 0.345343 0.290534 0.34368 -0.01952 0.476075 0.60353 0.5902
 
Sig. (2-
tailed) 0.006037 0.420445 . 0.000378 0.003054 0.000405 0.84561 0.000001 0.000001 0.000001
 N 102 102 102 102 102 102 102 102 102 102
dur
Correlation 
Coefficient 0.289531 0.05574 0.345343 1 0.242218 0.33197 0.160332 0.395246 0.447005 0.524525
 
Sig. (2-
tailed) 0.003162 0.577911 0.000378 . 0.014176 0.000653 0.107453 3.93E-05 2.48E-06 0.000001
 N 102 102 102 102 102 102 102 102 102 102
imaging
Correlation 
Coefficient 0.250369 -0.17696 0.290534 0.242218 1 0.360844 -0.01165 0.586792 0.496217 0.607664
 
Sig. (2-
tailed) 0.011149 0.075196 0.003054 0.014176 . 0.000195 0.907468 0.000001 0.000001 0.000001
 N 102 102 102 102 102 102 102 102 102 102
grade_r
Correlation 
Coefficient 0.401119 0.043176 0.34368 0.33197 0.360844 1 0.118371 0.55885 0.678988 0.841016
 
Sig. (2-
tailed) 2.94E-05 0.666555 0.000405 0.000653 0.000195 . 0.236047 0.000001 0.000001 0.000001
 N 102 102 102 102 102 102 102 102 102 102
ext.res
Correlation 
Coefficient 0.143175 -0.08471 -0.01952 0.160332 -0.01165 0.118371 1 0.044649 0.195495 0.219566
 
Sig. (2-
tailed) 0.151122 0.397248 0.84561 0.107453 0.907468 0.236047 . 0.65589 0.04894 0.026602
 N 102 102 102 102 102 102 102 102 102 102
event
Correlation 
Coefficient 0.456193 -0.10032 0.476075 0.395246 0.586792 0.55885 0.044649 1 0.60803 0.734251
 
Sig. (2-
tailed) 1.45E-06 0.315728 0.000001 3.93E-05 0.000001 0.000001 0.65589 . 0.000001 0.000001
 N 102 102 102 102 102 102 102 102 102 102
score_r
Correlation 
Coefficient 0.649348 0.044792 0.60353 0.447005 0.496217 0.678988 0.195495 0.60803 1 0.895587
 
Sig. (2-
tailed) 0.000001 0.654856 0.000001 2.48E-06 0.000001 0.000001 0.04894 0.000001 . 0.000001
 N 102 102 102 102 102 102 102 102 102 102
totalscore
Correlation 
Coefficient 0.640569 -0.01917 0.5902 0.524525 0.607664 0.841016 0.219566 0.734251 0.895587 1
 
Sig. (2-
tailed) 0.000001 0.848338 0.000001 0.000001 0.000001 0.000001 0.026602 0.000001 0.000001 .
 N 102 102 102 102 102 102 102 102 102 102
Correlation is significant at the 0.01 level (2-
tailed).
Correlation is significant at the 0.05 level (2-
tailed).
Coefficients(a)
Mode
l  
Unstandardized 
Coefficients  
Standardized 
Coefficients t Sig.
  B
Std. 
Error Beta   
1 (Constant) 6.59433E-15
3.76
E-08  1.75E-07 1
 age_r 1
8.55
E-09 0.257316
1.17E+0
8 0
 kps_r 1
8.64
E-09 0.256089
1.16E+0
8 0
 dur 1
1.2E-
08 0.182461
8327970
1 0
 imaging 1
9.63
E-09 0.22237
1.04E+0
8 0
 ext.res 1
1.23
E-08 0.161663
8100113
1 0
 grade_r 1 4.91 0.469825 2.03E+0 0
E-09 8
a
Dependent 
Variable: totalscore      
In the Spearman correlation the preoperative Karnofskys performance status of the patients , 
Grading of the tumor , presence of necrosis in imaging all correlated significantly with the 
outcome.Other  factors  like  age  ,  duration  of  symptoms and extent  of  resection  had  a  less 
significant correlation . The prognostic scoring applied in patients to predict the outcome had a 
significant correlation .
DISCUSSION
There have been various studies analyzing the impact of various prognostic factors on 
the outcome in gliomas. Age, duration of symptoms, preoperative KPS, CT appearance, extent 
of resection and histological grade have been found to be the most important among the various 
factors affecting the outcome in gliomas (Burger and Green 1987 ) (Ammirati 1987) (Burger 
1994)  (  Keles  2001)(Mariani  2004)  (Nakamura2000)(Pignatti  2002)  (Scerrati  1996) 
(2,1,11,13,24,28,33.)
Age as an important factor in determining the outcome has been emphasised in various 
studies.  Burger  and  Green  (1987)  found  negative  relationship  between  advancing  age  and 
duration of postoperative survival in glioblastomas(2).Laws et al (1984) found age of the patient 
was by far the most important variable in predicting length of survival(17).  Scerrati et al (1996) 
found significant positive association with survival at univariate analysis was found for the age 
group < 20 years,  for total and subtotal surgical resections in low grade gliomas(33).  In the 
present study, age less than 45 years correlated with better outcome than the other age groups. 
But age was not a major prognostic factor.
Duration of symptoms as a major prognostic factor has been emphasized by Takeuchi et 
al (1977)(38). In the present study also duration of symptoms more than one year favoured good 
outcome. 
Preoperative KPS as a major prognostic factor has been documented by Scerrati et al 
(1996)(33),  Nakamura  et  al  (2000)  and  Winger  et  al  (1989)(24,42).  In  the  present  study, 
preoperative KPS had a very significant impact on the outcome. KPS more than 80 favoured a 
good outcome.
CT Scan findings were found to influence the outcome by many authors. Wood et al 
(1988) have found that tumor size on the CT Scan was of prognostic importance independent of 
the other known prognostic variables(43). Schuurman and Troost (1997) found that presence or 
absence of contrast enhancement on CT was an important prognostic factor(35). McCormack et 
al (1977) also contrast enhancement on CT had a negative outcome in terms of survival(21). 
Berger et al (1994) highlighted the importance of tumour necrosis as a prognostic factor(2). In 
the present study presence of tumour necrosis and mass effect in the pre-operative CT affected 
the outcome adversely. 
Extent of tumour resection has been projected as the major prognostic factor by many 
authors.  Gross total resection of supratentorial glioblastomas and anaplastic astrocytomas is 
feasible and is directly associated with longer and better survival when compared to subtotal 
resection (Ammirati et al, 1987)(1). Scerrati et al (1996) have found that the most relevant factor 
affecting survival at the multivariate analysis was the extent of surgical resection(33). This has 
also been emphasized by Macdonald et al (1990),  Wood and Shapiro (1988),  Winger et al 
(1989), Mariani et al (2004), Nakamura et al (2000), Keles et al (2004), Tandon et al (1986)
(18,43,42,20,12,39). In the present study, gross total resection with residual tumour less than 5% had 
very favourable outcome. Those who had biopsy alone fared poorly. 
Histological grade has a very important significance. This has bee highlighted in the 
studies of  Winger et al (1989), Scerrati et al (1996), Pignatti et al (2002), Nakamura et al 
(2000), Mariani et al (2004)  (42,33,28,20). In the present study also the histological grade of the 
tumour  was a  major  prognostic  factor.  Patients  with low grade (Grade I  & II)  fared well. 
Majority of patient with grade III deteriorated functionally and majority with Grade IV tumours 
expired. 
Various attempts at prognosticating the outcome in gliomas have been made. Pignatti et 
al (2002) used age > or = 40 years,  astrocytoma histology subtype, largest diameter of the 
tumor > or  = 6 cm, tumor crossing the midline,  and presence of  neurologic deficit  before 
surgery  as  unfavorable  prognostic  factors  for  survival(28).  The  total  number  of  unfavorable 
factors present were used to determine the prognostic score. Schuurman and Troost (1997) used 
age,  duration  of  symptoms,  pre-operative  neurological  examination  and  CT-contrast 
enhancement to evolve a prognostic score. Numerical scoring was performed by giving either 1 
or 0 for: age > or < 40 years, symptom duration < or > 1 year, presence or absence of focal 
deficit,  and presence or  absence of CT-contrast  enhancement,  combining these factors  in a 
score ranging from             0-4(35). Curran et al (1993)(7) have devised a prognostic classification 
which is given the following table:
The  new  prognostic  scoring  system  evolved  in  this  Institute,  incorporating  all  the 
important prognostic factors like age, duration of symptoms, preoperative KPS, CT findings, 
histological grade and extent of resection is  a  very simple,  easy to apply and has  a good 
predictive  value.  Majority  of  patients  having a score  of  15 and more had good quality  of 
survival; majority of patients with score 10 and less expired; majority of those with score 11 to 
14, deteriorated in quality of life. 
LIMITATIONS OF THE STUDY
1) The patients have been  treated by different neurosurgical units with different protocols.
2) In this study only KPS on follow up has been used to determine the outcome . The length of 
survival has not been studied .
3) Follow up period for prospective patients were short.
4) Only quality of survival has been studied and duration of the survival has not been studied.
CONCLUSIONS
A study of various prognostic factors on the outcome of 102 supratentorial gliomas has 
been done and the following conclusions have been drawn from this study 
1) Preoperative  Karnofsky performance scale ( KPS ) , imaging  and histological grading of 
the  tumors  were  the  most  important  prognostic  factors  affecting  the  outcome  in 
supratentorial gliomas.
2) Age , duration of symptoms , extent of resection were less significant in determining the 
outcome.
3) The new prognostic scoring system for supratentorial gliomas is found to be very simple , 
devoid of any complex formulae or tables and easy to apply , it also correlates well with the 
outcome.
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APPENDIX – I
PROFORMA
Name                Age           Sex         I.P. No       M.I.N No      Unit               
Contact Address / No  
D.O.A.
D.O.S
D.O.D
CLINICAL DATA       PRE OPERATIVE  KPS :
                                       NEUROLOGICAL DEFICIT :
                                       SYMPTOMS & DURATION :
RADIOLOGICAL PARAMETER
                                      VOLUME OF TUMOR
                                       EDEMA 
                                       MASS EFFECT 
                                       MORPHOLOGY
                                       BASAL CISTERNS
HISTOLOGY :
       GRADING 
        SITE OF TUMOR 
SURGERY :
 EXTENT OF RESECTION AS DEDUCTED BY POST OPERATIVE CT
POST OPERATIVE FOLLOW UP
ADJUNCT  THERAPY
FOLLOW UP             PERIOD:                        KPS :
OUTCOME 
IMPROVED
STATIC
DETORIATED
EXPIRED
APPENDIX – III
EXTENT OF RESECTION
(A)     > 95%  RESECTION 
 
      
     PRE OPERATIVE         POST OPERATIVE
(B) < 95% RESECTION 
             PRE OPERATIVE        
             (C) BIOPSY                                                                POST OPERATIVE 
                                                                                                
             PRE OPERATIVE      
                                                                                               POST OPERATIVE
A : > 95% Resection 
B : < 95% Resection 
C : Biopsy
